Online Only Articles

Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival

Department of Hematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands;Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Hematology, Medical Center Leeuwarden, Dordrecht, the Netherlands
Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands
Department of Biostatistics, Albert Schweitzer Hospital, Dordrecht, the Netherlands;Department of Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands
Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands
Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands
Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands
Department of Hematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands
Vol. 102 No. 12 (2017): December, 2017 https://doi.org/10.3324/haematol.2017.175265